The clinical value of concomitant Epstein Barr virus (EBV)-DNA load and specific immune reconstitution monitoring after allogeneic hematopoietic stem cell transplantation-Reference-Cited by-同舟云学术

The clinical value of concomitant Epstein Barr virus (EBV)-DNA load and specific immune reconstitution monitoring after allogeneic hematopoietic stem cell transplantation

Published:2011-05 Issue:4 Volume:24 Page:224-232
ISSN:0966-3274
Container-title:Transplant Immunology
language:en
Short-container-title:Transplant Immunology

Author:

D'Aveni Maud,Aïssi-Rothé Lamia,Venard Véronique,Salmon Alexandra,Falenga Aude,Decot Véronique,Virion Jean Marc,Wang Yingying,Clement Laurence,Latger-Cannard Véronique,Tomowiak Cécile,Stoltz Jean François,Bordigoni Pierre,Bensoussan Danièle

Publisher

Elsevier BV

Subject

Transplantation,Immunology,Immunology and Allergy

Reference44 articles.

1. Risk of lymphoproliferative disorders after bone marrow transplantation: a multi-institutional study;Curtis;Blood,1999

2. Risks of developing Epstein-Barr virus-related lymphoproliferative disorders after T-cell-depleted marrow transplants. CAMPATH Users;Hale;Blood,1998

3. Risk factors for developing EBV-related B cell lymphoproliferative disorders (BLPD) after non-HLA-identical BMT in children;Gerritsen;Bone Marrow Transplant,1996

4. Risk factors for lymphoproliferative disorders after allogeneic hematopoietic cell transplantation;Landgren;Blood,2009

5. Prevention of Epstein-Barr virus-lymphoproliferative disease by molecular monitoring and preemptive rituximab in high-risk patients after allogeneic stem cell transplantation;van Esser;Blood,2002

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mechanistic Understanding of EBV+Lymphoproliferative Disease Development After Transplantation;Transplantation;2024-02-05

2. Immune Reconstitution After Allogeneic Haematopoietic Cell Transplantation: From Observational Studies to Targeted Interventions;Frontiers in Pediatrics;2022-01-11

3. Factors Associated with Post-Transplant Active Epstein-Barr Virus Infection and Lymphoproliferative Disease in Hematopoietic Stem Cell Transplant Recipients: A Systematic Review and Meta-Analysis;Vaccines;2021-03-19

4. Management of PTLD After HSCT;Post-Transplant Lymphoproliferative Disorders;2021

5. Management of PTLD After Hematopoietic Stem Cell Transplantation: Immunological Perspectives;Frontiers in Immunology;2020-09-16